Dr. Mohd Amin Mir

Director | Clinical Research

MS; MSc Clinical Research

"We act as an interface between laboratory (pre-clinical) and hospital (clinical trials) and focus on bring new discoveries and treatments for serious/unmet medical needs in minimum possible time. From the inception of a new chemical or therapeutic entity in early clinical development, we collaborate with medical fraternities and organizations to seek their valuable guidance and support to bring our new therapeutic modalities from bench to bed in shortest possible time to improve the overall health of mankind"

"We act as an interface between laboratory (pre-clinical) and hospital (clinical trials) and focus on bring new discoveries and treatments for serious/unmet medical needs in minimum possible time. From the inception of a new chemical or therapeutic entity in early clinical development, we collaborate with medical fraternities and organizations to seek their valuable guidance and support to bring our new therapeutic modalities from bench to bed in shortest possible time to improve the overall health of mankind"

5

Years at VMRC

11

Publications

1

Awards & Honors

Research and development are exhaustive teams work involving a great number of experts from different domains and their vigorous efforts together to bring new and better medicines to patients in the shortest possible time. Research and development can make all the difference when it comes to saving people’s lives or improving their quality of life. This effort involves pre-clinical and clinical phases and clinical research division of Venus Remedies Ltd is having a pool of experts in clinical domain and are primarily involved in guiding and assisting the drug development team in key activities related to the execution of clinical phases. The clinical research division of Venus Remedies Ltd is extensively working on new antibiotics and antimicrobial stewardship to address the current global concern of growing antibiotics resistances. There are quite a good number of research product in clinical phase which has shown quite encouraging and promising results to tackle the demand for new antibiotics to curb growing resistance.

Assist the research and development team in drafting strategies in the development of new drug candidates especially new antibiotics. Coordinate and collect valuable feedback from key opinion leaders (KOLs) on strategy drafted for developing new drug candidates. Support medical fraternity in the execution of the clinical phase of drug development like phase I-IV and investigator-initiated clinical trials.

  • M.Sc.-Clinical Research (Cranfield U.K.)
  • P.G.D.P.M.-Pharmaceutical Management (I. C. R. I. Delhi)
  • M.S.-Surgery (A.M.U. Aligarh)
  • Young Scientist Award at JCON-2009.

Copyright © 2019 VMRCINDIA All Rights Reserved